Literature DB >> 8027419

Medication withdrawal symptoms in obsessive-compulsive disorder patients treated with paroxetine.

N J Keuthen, P Cyr, J A Ricciardi, W E Minichiello, M L Buttolph, M A Jenike.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8027419     DOI: 10.1097/00004714-199406000-00010

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  9 in total

Review 1.  Antidepressant Withdrawal and Rebound Phenomena.

Authors:  Jonathan Henssler; Andreas Heinz; Lasse Brandt; Tom Bschor
Journal:  Dtsch Arztebl Int       Date:  2019-05-17       Impact factor: 5.594

Review 2.  Subtherapeutic doses of SSRI antidepressants demonstrate considerable serotonin transporter occupancy: implications for tapering SSRIs.

Authors:  Bryan B Shapiro
Journal:  Psychopharmacology (Berl)       Date:  2018-08-10       Impact factor: 4.530

Review 3.  Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders.

Authors:  N S Gunasekara; S Noble; P Benfield
Journal:  Drugs       Date:  1998-01       Impact factor: 9.546

4.  Hypotension following cardiac surgery associated with paroxetine and mirtazapine withdrawal.

Authors:  Kimberly J Novak; William I Douglas; Robert J Kuhn
Journal:  J Pediatr Pharmacol Ther       Date:  2008-01

5.  Discontinuation syndrome in dysthymic patients treated with selective serotonin reuptake inhibitors: a clinical investigation.

Authors:  Filippo Bogetto; Silvio Bellino; Raffaele Bonatto Revello; Luca Patria
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 6.  Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria.

Authors:  K Black; C Shea; S Dursun; S Kutcher
Journal:  J Psychiatry Neurosci       Date:  2000-05       Impact factor: 6.186

7.  Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.

Authors:  R H Foster; K L Goa
Journal:  CNS Drugs       Date:  1997-08       Impact factor: 5.749

Review 8.  Obsessive-compulsive disorder in elderly patients.

Authors:  C W Jackson
Journal:  Drugs Aging       Date:  1995-12       Impact factor: 3.923

Review 9.  Antidepressant discontinuation syndromes.

Authors:  P M Haddad
Journal:  Drug Saf       Date:  2001       Impact factor: 5.228

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.